PubRank
Search
About
Adnan Ezzat
Author PubWeight™ 15.14
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival.
Blood
2006
1.70
2
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.
J Clin Pathol
2006
1.24
3
Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience.
BMC Cancer
2007
1.08
4
Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy.
Am J Surg
2002
0.92
5
Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Cancer Epidemiol Biomarkers Prev
2006
0.88
6
Palliative care initiative for the Eastern Mediterranean Region: a proposal.
Ann Saudi Med
2005
0.83
7
Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Ann Hematol
2007
0.83
8
Emerging role of gammadelta T-cells in health and disease.
Blood Rev
2002
0.83
9
VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.
Am J Clin Oncol
2004
0.82
10
18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.
World J Surg
2003
0.80
11
Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.
Oncology
2008
0.80
12
A pilot trial of combination cisplatin, 5-fluorouracil and interferon-alpha in the treatment of advanced esophageal carcinoma.
Chemotherapy
2002
0.79
13
Phase II trial of cisplatin, 5-fluorouracil, and interferon-alpha-2B as first line treatment of advanced urothelial cancer.
Urol Oncol
2003
0.78
14
High epidermal growth factor receptor amplification rate but low mutation frequency in Middle East lung cancer population.
Hum Pathol
2006
0.77
15
Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyte-rich large B-cell lymphoma and lymphocyte-predominant Hodgkin lymphoma.
Hematol Oncol Stem Cell Ther
2010
0.77
16
High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East.
Hum Pathol
2006
0.76
17
Epstein-Barr virus infection is not the sole cause of high prevalence for Hodgkin's lymphoma in Saudi Arabia.
Leuk Lymphoma
2006
0.76
18
High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia.
Mod Pathol
2006
0.75
19
18-fluorodeoxyglucose positron emission tomography in cystic carcinoma of the breast.
Breast J
2002
0.75
20
The impact of the World Health Organization classification and clonality assessment of posttransplant lymphoproliferative disorders on disease management.
Arch Pathol Lab Med
2006
0.75